Efficacy of an Oral Skincare Supplement on Skin Aging: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial

口服护肤补充剂对皮肤老化的功效:一项为期 12 周的随机、双盲、安慰剂对照试验

阅读:2

Abstract

INTRODUCTION: Aging leads to structural and compositional changes in the skin, contributing to more wrinkles, less smoothness, and dryness. There is growing interest in oral non-invasive interventions to help ameliorate visual signs of skin aging. The purpose of this study was to evaluate the efficacy of an oral skincare supplement containing hyaluronic acid and wheat oil extract on parameters of skin aging in a diverse population. METHODS: Healthy adults (ages 26-64) were recruited and randomly assigned to the intervention group (n = 31) or placebo group (n = 32). The intervention group received an oral skincare supplement consisting of wheat oil extract and low molecular weight sodium hyaluronate, with a 12-week follow-up period. RESULTS: The intervention group demonstrated a significant reduction in crow's feet wrinkles and improvements in both facial and global skin smoothness beginning at week 8 and continuing to week 12, compared to the placebo group. Additionally, the intervention group exhibited significant increases in skin hydration and elasticity in the leg region relative to the placebo group. Dermatologists' evaluations revealed significant reductions in global scores of both deep and fine wrinkles from baseline to week 12, but only in the intervention group. By week 12, a greater proportion of participants in the intervention group reported improvements in fine lines and wrinkles, skin radiance/glow, skin resilience/elasticity, and overall signs of aging, with these changes being significantly different from the placebo group. CONCLUSION: An oral skincare supplement combining wheat oil extract and hyaluronic acid offers a comprehensive method for addressing skin aging, providing measurable clinical improvements in various skin parameters and enhancing subjective perceptions of skin health and appearance. TRIAL REGISTRATION: ClinicalTrials.gov identifier, NCT06083402.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。